Comparative Study
doi: 10.1002/ijc.2910450115.
Effect of the EBNA-2 gene on the surface antigen phenotype of transfected EBV-negative B-lymphoma lines
Affiliations
- PMID: 2153641
- DOI: 10.1002/ijc.2910450115
Item in Clipboard
Comparative Study
Effect of the EBNA-2 gene on the surface antigen phenotype of transfected EBV-negative B-lymphoma lines
Int J Cancer.
.
Abstract
Two EBV-negative B-lymphoma cell lines with different phenotypes were transfected with the Epstein-Barr virus EBNA-2 gene. The effects on the expression of 8 B-cell surface markers were analyzed by immunofluorescence methods. In one of the EBNA-2 transfected cell lines, the expression of the CR2 receptor CD21 was induced and the expression of CD23 was enhanced. The results suggest that the EBNA-2 gene is involved in the regulation of CD21 and CD23 in EBV-carrying cells.
Similar articles
-
Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23.Proc Natl Acad Sci U S A. 1987 May;84(10):3452-6. doi: 10.1073/pnas.84.10.3452. Proc Natl Acad Sci U S A. 1987. PMID: 3033649 Free PMC article.
-
Induced CD25 expression in a human B-lymphoma cell line transfected with the Epstein-Barr virus nuclear antigen 2 gene.Microbiol Immunol. 1992;36(5):479-94. doi: 10.1111/j.1348-0421.1992.tb02046.x. Microbiol Immunol. 1992. PMID: 1325025
-
B cell phenotype-dependent expression of the Epstein-Barr virus nuclear antigens EBNA-2 to EBNA-6: studies with somatic cell hybrids.J Gen Virol. 1991 Dec;72 ( Pt 12):3025-33. doi: 10.1099/0022-1317-72-12-3025. J Gen Virol. 1991. PMID: 1662694
-
Analysis of viral gene expression and genome persistence in CD23-positive and -negative subpopulations of Epstein-Barr-virus-infected BL2 cells.Intervirology. 1994;37(5):236-44. doi: 10.1159/000150384. Intervirology. 1994. PMID: 7698878
-
Cytokine mediated induction of the major Epstein-Barr virus (EBV)-encoded transforming protein, LMP-1.Immunol Lett. 2006 Apr 15;104(1-2):83-8. doi: 10.1016/j.imlet.2005.11.003. Epub 2005 Dec 1. Immunol Lett. 2006. PMID: 16386314 Review.
Cited by
-
Biochemical characterization of Epstein-Barr virus nuclear antigen 2A.J Virol. 1991 Jul;65(7):3779-88. doi: 10.1128/JVI.65.7.3779-3788.1991. J Virol. 1991. PMID: 1645792 Free PMC article.
-
Epstein-Barr Virus nuclear protein EBNA3A is critical for maintaining lymphoblastoid cell line growth.J Virol. 2003 Oct;77(19):10437-47. doi: 10.1128/jvi.77.19.10437-10447.2003. J Virol. 2003. PMID: 12970429 Free PMC article.
-
Germinal center cytokine driven epigenetic control of Epstein-Barr virus latency gene expression.PLoS Pathog. 2024 Apr 29;20(4):e1011939. doi: 10.1371/journal.ppat.1011939. eCollection 2024 Apr. PLoS Pathog. 2024. PMID: 38683861 Free PMC article.
-
Epstein-barr virus (EBV) nuclear protein 2-induced disruption of EBV latency in the Burkitt's lymphoma cell line Akata: analysis by tetracycline-regulated expression.J Virol. 1999 Jun;73(6):5214-9. doi: 10.1128/JVI.73.6.5214-5219.1999. J Virol. 1999. PMID: 10233991 Free PMC article.
-
Germinal Center Cytokines Driven Epigenetic Control of Epstein-Barr Virus Latency Gene Expression.bioRxiv [Preprint]. 2024 Jan 3:2024.01.02.573986. doi: 10.1101/2024.01.02.573986. bioRxiv. 2024. Update in: PLoS Pathog. 2024 Apr 29;20(4):e1011939. doi: 10.1371/journal.ppat.1011939. PMID: 38260430 Free PMC article. Updated. Preprint.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
